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People are exposed to many unnatural
chemical combinations in workplaces,
surroundings, diet, or medications. Most of
these exposures occur at very low doses for
which individual chemical toxicity is not
expected, but unrecognized interactions
could result. Environmental toxins occur at
exposures (micrograms per kilogram body
mass) for which studies of high-dose mecha-
nisms may no longer apply. Full toxicologic
profiles of all chemical mixtures, including
dose–response extrapolations to realistic
exposures, is a prohibitive analytical prob-
lem, even for a restricted class of chemicals
such as pesticide residues on food. We pre-
sent an approach to probing in vivo interac-
tions of toxin mixtures at relevant low doses,
using a monitor compound to report the
response of a biochemical pathway shared by
mixture components. This approach has the
potential for revealing unexpected interac-
tions arising from physiochemical effects
throughout a living test organism.
We tested this approach by measuring
modifications of tissue binding using com-
mon organophosphate (OP) and pyrethroid
pesticides. The toxic mechanism of OPs is
primarily disruption of the cholinergic path-
way in nerve transmissions. Cholinesterase
inhibition is seen in high-dose exposures of
most OPs, with a wide variance in effective
toxicity (1,2). Serine hydrolases are found in
many biochemical pathways, including
immunity and respiration, and these proteins
are also classic OP targets with potential
toxic consequences (3). We chose diiso-
propylfluorophosphate (DFP) as a tracer
compound because it is an anticholinesterase
pharmaceutical, a binder to serine hydrolases,
and a simulant of offensive nerve agents that
inhibits target proteins through covalent
attachment. This study included parathion
(PTN) and permethrin (PER), two of the
most commonly used insecticides of the OP
and pyrethroid classes, respectively. An addi-
tional quaternary cholinesterase inhibitor,
pyridostigmine bromide (PYB), was added to
the group to represent natural cholinergics or
protective pharmaceutical intake. The chem-
ical combination has minor relevance to
exposures believed related to Gulf War syn-
drome (4) but is also relevant to domestic
exposures of insecticides and pediculocides.
OP metabolites are found in human urine
at levels of 0.1 µmol/kg, even for children (5).
These trace concentrations are insufﬁcient for
quantifiable inhibition of enzymes through
activity assays, the standard technique for
quantification. This study used chemical
exposures of < 0.01 µmol/kg/day to maintain
undisturbed enzymatic activities. Highly sen-
sitive quantitation of the monitor compound
is required so all exposures remain at
environmental concentrations or less.
Sensitive quantitation is possible using
isotope-labeled compounds whose labels have
very low natural concentrations, as do
radioisotopes. Isotope decay detection is inef-
ﬁcient, however, so we used accelerator mass
spectrometry (AMS) to quantify a 14C iso-
topic label on tracer compounds at attomole
levels with 1–5% precision (6). This sensitiv-
ity quantitates even tracer doses in highly
fractionated tissue samples from small animal
models such as mice. A 30-g mouse contains
about 1.4 becquerels (Bq) (37 pCi) of natural
14C, and AMS easily quantiﬁes tracer 14C at
5% above natural (75 milliBq or 2 pCi tracer
14C/mouse). A dynamic range of 1,000 in a
tracing experiment thus needs no more than
2 nCi or 75 Bq tracer/animal. The Nuclear
Regulatory Commission has long ruled that a
yearly nonradioactive disposal of up to 1 µCi
of 14C-containing biologic material with
concentrations <50 nCi/g is acceptable as
nonradioactive waste (7). With a total of 
<2 nCi/30-g mouse, this disposal limit is well
above the levels in AMS tracing experiments.
The typical AMS sample contains 1 mg car-
bon, obtainable from 25 µL plasma, 7 mg
brain tissue, or the red blood cells (RBCs)
from 15 µL whole blood. These small sample
sizes are readily available from mice. DFP is
available at high speciﬁc activity (~2 14C/mol-
ecule), making it a particularly sensitive probe
of delivered protein inhibition. DFP retains
this 14C label when bound to enzymes and is
easily dosed orally in food.
The reporter DFP binds rapidly and
irreversibly to serine hydrolases in the brain,
in other nerve tissue, on RBC membranes,
and in skeletal muscle, including membrane
esterases. It also binds to soluble plasma
hydrolases, including coagulation factors,
carboxylesterase, and butyrylcholinesterase
(BChE), and to cytosolic serine proteases,
but is hydrolyzed to the nonbinding diiso-
propylphosphoric acid (DPA) by circulating
and hepatic A-esterases (8,9). Although DFP
is frequently used as an enzyme inhibitor to
identify the targets of serine-based hydrolysis
(10), the complement and relative affinities
of DFP-binding proteins for mammals 
in vivo is unknown. Two primary protein
targets in homogenized rat brain in vitro are
OP-reactive sites, along with six or more
minor targets (11); similar numbers of both
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membrane and cytosol proteins are found in
homogenized chicken brain in vitro (12).
Neither of these examples addresses the
likely targets or extent of DFP binding that
occurs through natural distribution and
metabolism in living animals at low doses.
The hydrophobic DFP will primarily report
levels of dissolution within lipids, binding to
cell membrane proteins, or to plasma-soluble 
proteins. Our procedure attempted to pre-
vent postdissection binding to cytosol pro-
teases during sample acquisition. A
follow-up of this study will use remaining
tissues to identify DFP-binding proteins in
the living mouse brain and plasma, along
with their binding probabilities.
Only trace amounts of DFP will be
bound to proteins at very low doses, and any
unbound compound is rapidly cleared (13).
Interanimal and even intratissue variations in
hydrolase concentrations are expected to be
much greater than the trace concentration of
the bound reporter compound. Traditional
enzyme activity assays respond to these ani-
mal and tissue variations, which mask physio-
logically induced changes at tracer levels. Our
reporter fluctuations are instead expected to
reﬂect physiologic or physiochemical changes
brought about by coexposed chemicals that
modulate the amount of reporter reaching a
tissue or binding to enzymes. Stress can affect
cerebral-vascular transmission (14), requiring
experimental design that either quantifies or
minimizes stress effects that might mask those
resulting from chemical coexposures. We
designed our experiment to eliminate stress
by avoiding handling of the mice throughout
the procedures until euthanasia.
The pesticides in our chemical mixtures
are known at high doses to perturb
numerous biologic pathways, as they possess
hormonal activities (15), affect enzymatic
regulation (16), induce membrane perme-
abilities (17), and produce cytotoxicity 
in vitro (18), among other physiologic effects
not directly related to their esterase interac-
tions. Chronic low-level exposures are impli-
cated in cognitive dysfunctions (19), but
carefully controlled animal studies have
shown no detrimental cognitive effects at
chronic daily doses ranging up to 500 µg/kg.
However, direct acetylcholinesterase (AChE)
inhibition was measurable at the highest
doses (20). Thus, enzyme-binding com-
pounds at doses of 1 µg/kg are suitable
probes of how chemical mixtures of pesti-
cides might affect physiology and chemistry
but should have little effect on mouse health
and behavior. The goal of our work was to
quantify any changes in tissue exposures of
DFP that could be ascribed to subchronic
preexposure to other anthropogenic esters at
the very low doses obtained from household
or occupational exposure.
Materials and Methods
Chemicals. [14C]-DFP (speciﬁc activity = 160
mCi/mmol) was purchased from New
England Nuclear Life Science Products, Inc.
(NEC-378; Boston, MA, USA). Uniform ring
label[14C]-PTN (9.2 mCi/mmol) and [14C]-
PER (9.8 mCi/mmol) were purchased from
Sigma Chemical Co. (31396-3, and Z9999;
St. Louis, MO, USA). Unlabeled PTN and
PER were purchased from Chem Service (PS-
95 and PS-758; West Chester, PA, USA) and
assayed > 98.5% purity. PYB and unlabeled
DFP were purchased from Sigma (P9797 and
D0879). [14C]-DFP was diluted in unlabeled
DFP to adjust specific isotope activities to
desired levels. Purina 5K92 Pico-Vac Rodent
Soft Mix food came from PMI Nutrition
International (Richmond, IN, USA). All
other chemicals and solvents were of the
highest grade readily available from commer-
cial suppliers.
Test animals. CD2/F1 male mice were
obtained from Charles River (Wilmington,
MA, USA) at 6–8 weeks of age and quaran-
tined for 5 days for acclimatization and to
ascertain health before moving to an
Association for Assessment and Accreditation
of Laboratory Animal Care–approved animal
care facility for experiments. Protocols were
approved by the Lawrence Livermore
National Laboratory Institutional Animal
Care and Use Committee, and all care and
treatment conformed to the U.S. Public
Health Service policy on the humane care
and use of laboratory animals. Mice were
housed individually in plexiglass containers
with wire cage tops and lined with shaved
wood animal bedding. Food and water were
provided ad libitum, except as noted below,
during a 12-hr light/dark cycle at 20°C.
Mice were either not, or minimally, han-
dled throughout the experimental proce-
dures to minimize stress-induced differences
among animals.
Pharmacokinetic study. Mice received
intraperitoneal (ip) DFP doses of 100 ng/kg
(13.6 pmol, 2.2 nCi/mouse) and were sam-
pled for tissue kinetics at 1, 12, 24, 48, and
168 hr. DFP was dissolved in hexane/poly-
ethylene glycol and added to peanut oil for
dosing. Triplicate mice were weighed and
sacrificed by CO2 asphyxiation at appropri-
ate times. Blood (0.25–0.5 mL) was imme-
diately obtained by cardiac puncture with
syringes prewetted with 100 mM EDTA,
transferred to plastic tubes containing 2–3
drops of EDTA, mixed, and stored on ice.
The following tissues were then obtained
and stored on ice: a piece of the right femur
muscle, liver, spleen, and brain. The brain
was cut in half sagitally, the left hemisphere
placed in a homogenization tube (see
below), the right half hemisphere in a
plastic tube, and both tubes stored on ice.
The blood was centrifuged at 1,000 rpm for
5 min to separate plasma and RBCs.
Samples were either processed immediately
for AMS analysis or stored at –70°C.
Chemical dosing. Chemicals for
dose–response and chemical mixture studies
were presented in food to reduce stress to the
animals. Mice were placed on a fast/feed regi-
men that removed food in the evening, pre-
sented 300–500 mg of moist food in the
morning containing the particular chemical
dose, and resumed availability of dry food 
ad libitum until the next evening. The moist
food consisted of a 1/1.6 mixture of Purina
5K92 Pico-Vac Rodent Soft Mix (PMI
Nutrition International)/distilled water pre-
pared each morning. This food/water consis-
tency prevented the mice from handling the
food during consumption. Aliquots of the
food were transferred by spatula into the bulb
of a plastic disposable transfer pipette that
was cut with scissors so food retained in the
bulb was accessible to the mice. Chemicals
were added to the food in 10–40 µL veg-
etable oil or ethanol diluent vehicles. The
modified pipettes containing the food were
wedged between the bars of the wire cage top
so the food was suspended approximately 
3 cm from the cage bottom. Mice consumed
the food within 15–30 min, after which
pipettes were removed from the cage. More
than 80%, >95% in most cases, of the moist
food was consumed by the mice.
Dose–response study. Five mice per dose
group were acclimated to the fast/feed regi-
men for 5 days prior to dosing. The moist
food was amended with the 14C chemicals
immediately prior to dosing by pipetting
10–40 µL oil or alcohol vehicle containing
the radiolabel. Doses of 14C-labeled PER,
PTN, and DFP ranged from 500 ng to 500
µg kg body weight, except for the PTN,
which extended to 2 mg/kg. Actual doses
were calculated from body mass at euthanasia
and percentage of consumed carrier food.
14C-labeled compounds were diluted with
unlabeled equivalents to maintain the optimal
tissue content of 14C for accurate AMS quan-
titation (approximately 2 nCi/mouse, pro-
ducing an animal-averaged concentration
50–100 times the natural 14C). Control mice
were simultaneously fed moist food mixed
with an equal volume of vehicle. Dry food
and water were available ad libitum until
euthanasia at 48 hr postdosing. Blood and tis-
sues were harvested as described above. Two
mice per PTN dose group were transferred to
clean animal bedding immediately after dos-
ing. Fecal pellets were sieved from the cage
bedding of these mice to determine bioavail-
ability by quantifying unabsorbed [14C]-PTN
in the pellets. Pellets were homogenized and
combusted using an OX300 Biological
Oxidizer (Harvey Instrument Corporation,
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Hillsdale, NJ, USA) for liquid scintillation
counting. Recovery efﬁciency of the oxidizer
was measured at 99.2% using spiked controls.
Chemical mixture study. Moist food in
presentation pipettes was supplemented with
1 µg/kg PTN, PER, PTN plus PER, or
blank solvent, all with and without 50 µg/kg
PYB through a 5-day fast/feed cycle. Four
mice per each mixture group were then
dosed with 1 µg/kg [14C]-DFP in a final
moist food presentation. Dry food and water
were available ad libitum until euthanasia at
48 hr postdosing. Blood and tissues were
harvested as described above.
Tissue preparation. The left hemisphere
of each brain was placed in a 2.0-mL plastic
tube with 1.0 mL water prior to violent agi-
tation in a Biospec Mini-Beadbeater
(Biospec Products, Bartlesville, OK, USA)
for 10 sec to disrupt the cells and solubilize
residual blood. Unbound [14C]-DFP and
soluble proteins were removed by three
sequential centrifugations at 10,000×g in
0.5 mL water for 8 min each, with immedi-
ate supernatant removal to avoid cell mem-
branes refloating from the pellet. Sequential
washes indicated more than 99% of the sol-
uble isotope (bound or unbound) was
removed from the tissue after three rinses.
Lipid membrane material was not separated
from remaining cellular components, and
all bound isotope was assumed to represent
primarily membrane binding.
RBCs were recovered from whole blood
by centrifugation and removal of the plasma.
Aliquots of muscle, liver, spleen, RBC,
plasma, and rinsed brain containing 1–5 mg
carbon were packaged for AMS sample prepa-
ration. All samples were dried in a vacuum
centrifuge and converted to graphite for
introduction into the LLNL AMS ion source.
Statistics. Three to five mice provided
data for each experimental condition. All
chemical mixture determinations included
four mice. Kinetic data were analyzed by a
linear compartment model developed in
Berkeley Madonna software (University of
California, Berkeley, CA, USA). Mixture
exposure effects were analyzed for signiﬁcance
(p ≤ 0.05) using unpaired, 2-tailed t-test with
InStat software (Graphpad Software Inc., San
Diego, CA, USA) and expressed as medians
with the standard error in the median. Very
broad data distributions were prevalent in the
sampled muscle tissue, which was not
homogenized, and in short-time kinetic data
with rapid changes in tissue concentrations.
Homogenized brain and well-mixed plasma
showed no difference between means and
medians within the calculated errors,
conﬁrming near-normal distributions.
Results and Discussion
The bioavailability of PTN delivered in the
moist food ranged from 98.7 to 99.7%, based
on the measured 14C content of the feces col-
lected in the dose–response study. The
dose–response data for PTN showed low
(<20%) retention of the PTN isotope label at
48 hr, indicating that the majority of the label
was hydrolyzed and excreted as p-nitrophenol
in urine between dosing and euthanasia. Any
urine contamination of the recovered fecal
pellets would only decrease the quantified
bioavailability, an effect that must be minimal
given our measured results. We concluded
that the chemical delivery in food was efﬁcient
and avoided the confounding physical factor
of stress on the study animals from handling
or from living in metabolism cages.
The kinetic responses of [14C]-DFP in
plasma, RBC, and brain are shown in Figure 1 
for times between 1 hr and 1 week, along
with ﬁtted curves from a simple compartmen-
tal model of protein-bound DFP in Figure 2.
A-esterases hydrolyze DFP to DPA with a
maximum velocity of more than 1 mol/hr,
rapidly eliminating most of the maximum
concentration of 11 nM DFP. This rapid
elimination is seen in the ﬁrst 12 hr. The 1-hr
data for RBC and brain imply inefficiencies
of removing plasma from these samples at 10
and 0.5%, respectively. Intact DFP has a
higher reaction rate with plasma protein,
including BChE (350/µM-hr), than with the
bound proteins of the RBCs or the brain
(e.g., AChE 14/µM-hr), resulting in an
expectation of RBC binding that is lower
than plasma-bound levels and very low brain
labeling in the early exposure. The long-term
plasma clearance time (48 hr) matches that
found by Martin (13), but the brain binding
relative to plasma is a factor of 10 lower than
that found by Martin using a 10,000-fold
higher dose. The brain clearance is more than
a factor of 2 slower than found in that high-
dose study. The 100 ng/kg DFP dose pre-
sents 16 pmol to a 30-g mouse whose blood
volume is 1.3–1.6 mL (21), for a maximum
blood concentration of 11 nM. This repre-
sents just 0.001% of the Michaelis-Menten
concentration of DFP metabolism in mouse
blood and tissue (22), allowing linear model-
ing that assumes the concentrations of meta-
bolic enzymes remain essentially unchanged
by this dose throughout the exposure and
clearance. The measurements and model rep-
resent the regeneration and elimination of the
enzyme-substrate pair, as neither the metabo-
lized free DPA nor the recycled protein com-
ponents are able to further label proteins.
Therefore, the model does not return
resuspended components containing tracer
14C to the plasma pool.
The fitted model and its transport
parameters (in units per hour) are shown in
Figure 2. A storage and release compartment,
assumed to be lipid, is required to correctly
model the retention in plasma binding at 24
hr. We have seen similar kinetic behavior for
other lipophilic pesticides in mice (23), and
the Martin’s kinetic proﬁles of DFP show the
same delayed peak (13). Peak AChE inhibi-
tion occurs 24–48 hr after PTN and chlor-
pyrifos exposures (24). Anticholinesterases
can have differing peak binding times to
esterase in vitro (25), casting some doubt on
the need for this purely physical delay com-
partment. However, the rapid metabolism of
DFP argues for some sort of chemical or
physical protection of the fluorine during
this delay. The lipid partition coefﬁcient for
DFP is more than 10 times that for liver,
kidney, and perfused tissue (22), so the
assumed model of lipid storage delay is plau-
sible; however, the compartment may also
represent a delayed chemical interaction.
The model and data show that isotope
retention is achieved primarily through pro-
tein binding by the 48-hr point for both
RBC and brain, which forms the basis of
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Figure 1. Temporal behavior of protein-bound
[14C]-DFP is shown for plasma (circle), RBC (dia-
mond), and brain (square) after a 100-ng/kg ip
dose. Model concentrations are given for both
bound (dotted lines) and total components of DFP
in the sampled compartment.
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Figure 2. The compartmental model used to ﬁt the
measured kinetics of the ip dose of DFP shows the
transfer coefficients of the fit plotted in Figure 1.
Three compartments make up the measured
plasma pool: circulating free DFP, the metabolized
phosphoric acid of DFP (DPA), and the compound
bound to soluble enzymes (EZM). Other compart-
ments include the liver (LIV), RBCs, and brain
(BRN). Clearance from bound components to 
excreta (XCR) is assumed rapid compared with
plasma enzyme turnover. Transfer coefficients
have units of per hr.sampling the mixture-exposed animals at that
time. Buchholz et al. found a 15-hr mean
lifetime for unbound PER, implying that the
48-hr delay is sufficient in clearing that
unbound compound also (26). Enzyme
regeneration or cell turnover removing the
tracer label from both RBC and brain is mod-
eled at 7.5 days mean lifetime. The modeled
mean life of plasma-bound DFP (48 hr) is
similar to measured lifetimes of other plasma
proteins, such as albumin (27).
Dose–response study. The dose responses
of DFP, PTN, and PER were measured for
assurance that differences detected in multi-
chemical exposures were mixture effects rather
than unrecognized threshold effects of a single
compound. Plots of dose response from
dietary intake in Figure 3 showed low survival
from ﬁrst-pass metabolism for DFP and PER,
with plasma concentrations only 5–10% the
averaged body dose. Metabolism and clear-
ance of high-dose PTN was sufficient to
reduce the plasma concentration of intact
PTN or its metabolized leaving group to
0.1% of the exposure concentration at 48 hr.
Plasma partitioning to RBC was similar for
DFP and PER. PTN, or the labeled metabo-
lite p-nitrophenol, showed preferential uptake,
perhaps lipophilic, to RBC over remaining in
plasma. PER partitioned into the brain at only
10% the rate of DFP for equivalent body dose
(Figure 3C), despite its high lipophilicity.
Retained PTN label had signiﬁcantly nonlin-
ear dose response in the plasma and brain,
with relatively greater loss of the labeled frac-
tion at higher doses. PER showed signiﬁcant
nonlinearity in plasma, with greater retention
at higher doses. Dose responses were linear
within measurement and ﬁtting uncertainties
for all other compounds and tissues. No
threshold effects were noted near the planned
mixture dose of 1 g/kg.
DFP tissue concentrations from oral
exposures differ markedly from those of the
ip exposures used in determining kinetics.
RBC and brain concentrations of DFP are 
79 ± 16% and 53 ± 13%, respectively, of that
of plasma concentration, as opposed to the 20
and 5.4% levels observed at 48 hr in the ip
kinetic data. The extrapolated response for an
oral 100-ng/kg dose predicts a brain concen-
tration of 0.5 pg/g, a factor of 2 lower than
the concentration measured 48 hr after the ip
dose. In contrast, the plasma and RBC con-
centrations for oral exposure were a factor of
30 and 10, respectively, lower than those
from ip exposure at equivalent extrapolated
doses. Digestive hydrolysis of DFP to a non-
binding DPA may be signiﬁcant in oral expo-
sures, greatly reducing the active component
available for binding to circulating protein
and cells, but that low plasma concentration,
perhaps distributed on lipoproteins, remained
nearly as effective in entering the brain and
binding to RBC.
Chemical mixture study. Table 1 gives the
median tissue concentrations of [14C]-DFP,
with and without subchronic PYB, at ppt for
groups of animals unexposed (DFP only) and
preexposed to PTN, PER, and PTN and
PER together. Control data for animal han-
dling, tissue isolation, and measurement were
obtained from animals receiving equivalent
treatments with moist food containing only
vehicle solvents. These control tissues all con-
tained within 2% of the expected natural 14C
contents (108 amol 14C/mg carbon). This
natural 14C was subtracted from all tissue
measurements before converting the remain-
ing 14C signal to equivalent [14C]-DFP con-
centrations. The uncertainty in controls
represents <0.03 pg DFP equivalents/g tissue
and is incorporated into the uncertainties
stated in the table and shown in ﬁgures. Liver
and spleen tissues were not measured from
the PYB groups. These highly perfused tissues
retained high levels of bound DFP even after
48 hr, up to 10 times those found in plasma.
Muscle also retained more than twice the
concentration of DFP tracer as plasma, RBC,
and brain. Uncertainties in these higher
retention tissues arise from sampling and cir-
culatory variations but also from the measure-
ment procedure. AMS is highly sensitive for
low levels of isotope, but instrumental correc-
tions and uncertainties increase at the high
concentrations found in these tissues.
Figure 4 summarizes the [14C]-DFP
binding in tissues, without (Figure 4A) and
with (Figure 4B) PYB dosing. Chemical
coexposures did not affect absorption or dis-
tribution of the reporter DFP, as seen by the
constant plasma, muscle, liver, and spleen
concentrations. Only brain samples have
consistent changes in DFP binding for all
preexposures, with DFP increasing by 32,
27, and 43% for PTN, PER, and PTN-PER
exposures, respectively. The increases persist
with the coadministered dose of PYB (25,
24, and 38%). The combined effect of PTN
with PER was the pythagorean sum (the
square root of the sum of the squares) of the
individual changes.
The increased level of brain-bound DFP
could arise through greater absorption or
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Figure 3. Tissue concentrations of [14C]-PTN, [14C]-
PER, and [14C]-DFP in plasma, RBC, and brain are
shown as functions of the orally administered dose
corrected for mouse body mass and dose con-
sumption. Power fits to the data are shown. The
only significantly nonlinear data are for PTN
residues in plasma and brain and PER in plasma. No
threshold effects are found near 1-µg/kg doses.
Measurement uncertainties are present on all data.
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Table 1. The median values of [14C]-DFP concentrations are expressed in picograms DFP per gram tissue
(± the standard error in the median) for the blood and four tissues from mice coexposed to pesticides and
PYB.
Tissue DFP only + PTN + PER + PTN + PER
Plasma 9.01 1.38 7.84 0.90 8.73 0.99 7.74 0.88
+ PYB 7.15 1.15 7.23 0.44 7.70 1.15 7.19 0.81
RBC 7.68 1.63 6.77 2.95 9.11 0.93 12.7 2.90
+ PYB 5.54 0.81 6.46 1.18 7.67 2.04 8.50 2.91
Brain 4.09 0.50 5.42 0.19 5.19 0.14 5.85 0.47
+ PYB 3.60 0.28 4.49 0.24 4.48 0.22 4.97 0.49
Muscle 13.5 4.3 13.1 2.9 11 14 18.6 5.9
+ PYB 6.3 4.4 12.3 2.5 7.7 3.0 8.3 7.1
Liver 78 16 57 18 90.1 5.7 87 12
Spleen 25.2 4.7 21.3 2.0 36.0 7.5 22.5 3.6greater retention. Greater retention implies
increased brain protein binding by DFP
inﬂuenced by the presence of the other com-
pounds. AChE activity in rat brain signifi-
cantly increased after 60 mg/kg PER dosed
both subchronically for 7 days and acutely
(28), along with modifying other enzyme-
based membrane properties. Our PER expo-
sure dose was 0.002% of that level and was
unlikely to cause upregulation of serine
hydrolases in the brain. Synergistic effects
such as multisite binding that effectively
increases binding affinity are possible
(29,30). The DFP delivered to the brain is
approximately 4 pg/g, or 20 pM. AChE,
only one of the DFP-binding proteins, is
present in mammal brain at many tens to
hundreds nanomolar (28), providing binding
proteins already in large excess of the DFP
and minimizing the probability of coincident
binding on a given protein. Thus, induction
of enzymatic production by pesticides should
not change retention.
The sublinear pythagorean additivity
might indicate an overall process of circula-
tion or brain absorption nearing saturation,
or the interaction of at least two DFP
absorption processes sensitive to the pesti-
cides in varying degrees. The brain absorp-
tion of DFP is lipophilic, which argues
against specifically mediated absorption
required for the latter interpretation.
Pesticide disturbance of the hypothesized
lipid storage (Figure 2) and reemergence of
the DFP preferentially in the lipid-filled
brain could contribute to the observed effect,
but tissue specificity would have to be high
for the brain signal to be so unlike the RBC
or muscle, which show no pesticide-induced
increases. Instead, the brain level most likely
reflects the concentration of active tracer
compound reaching the brain, suggesting
that a 25–45% increase in cerebral-vascular
DFP transmission arose from pesticide
exposures at 1 µg/kg.
The effect of PYB exposure is summa-
rized in Figure 5, where the percentage
changes in [14C]-DFP tissue concentrations
due to PYB are shown for all comparable
experimental conditions. The brain data
show some significant differences consistent
among all pesticide exposures. PYB does not
easily pass the rodent blood–brain barrier,
even under stressed conditions (31,32),
although one study suggests otherwise (33).
The compounds, even in total, remain at
tracer concentrations (~100 nM maximum
whole-body average for PYB) that can cause
only minor competitive inhibition of pro-
teins. Abou-Donia et al. see no significant
change in brain enzyme activities for AChE,
choline acetyltransferase, m2 muscarinic
acetylcholine (ACh) receptor, and nicotinic
ACh receptor at PYB doses 25 times greater
than those used here, despite significant
changes in a measure of locomotor skills
most affected by PYB alone (34). Our
observed 10–15% reduction in brain DFP
binding does not fit a dose-dependent
extrapolation of those higher-dose studies.
An induction of protective esterase activity
elsewhere in the body leading to lower DFP
plasma concentration is consistent with our
observation, and we do see a decrease of DFP
in plasma under PYB exposure with and
without pesticides. Any such induction of
enzyme activity was speciﬁc to elimination of
active DFP, however, leaving the PTN and
PER enhancement of brain DFP unaffected
by PYB. PYB may possess a protective mech-
anism of action unrelated to the minimal
competitive enzyme binding possible at these
doses. This PYB dose is only 4% of the pro-
phylactic dose used by service people in the
Persian Gulf War to protect against nerve
agent exposure. That dose was chosen to tem-
porarily shield about 30% of nerve esterase
from OP binding (34). The 10% protection
observed here is a factor of 10 greater than a
linear extrapolation of that effect.
Conclusions
We demonstrated a method for detecting
tissue-speciﬁc effects due to low-dose exposures
to multiple compounds. The concentrations of
bound DFP in all tissues reflect the level of
active compound reaching the tissue shortly
after the oral [14C]-DFP exposure, with possi-
ble modulation of uptake, distribution, and
binding due to the preexposed compounds.
These data showed that common pesticides
signiﬁcantly change the amount of toxin that
reaches the brain at concentrations that would
not have measurable effects on traditional
enzyme activity assays. These pesticides were
provided by oral exposure doses that are com-
mensurate with doses available through normal
ingestion of sprayed foods, drinking of surface
waters, or use of home pesticides. The mecha-
nism appears to be an increase in cerebral-vas-
cular transmission of DFP that is independent
of protective effects from transient binding by
PYB. If the increase in brain DFP concentra-
tions is due to greater barrier permeability,
other toxins and even pathogens may also
obtain greater access to brain tissue during
low-level pesticide exposure. This would rep-
resent an increase in neural toxicity that
results from alternative mechanisms from the
primary decrease in enzyme activity, a usual
measure of toxic end points. The sensitivity of
AMS for isotope-labeled tracer compounds
can be used to probe the physiologic responses
of speciﬁc biochemical pathways to multiple
compound exposures.
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